CASE STUDY
Therapeutic Gene Editing for Genetic Disorders
Advanced the client’s entry into precision medicine by enabling targeted treatment strategies for inherited blood disorders.
Situation
The client aimed to leverage gene-editing technologies to address genetic diseases with limited or burdensome treatment options, including conditions requiring lifelong management.
Solution
A targeted research and development initiative focused on precision targeting strategies while minimizing off-target genetic effects.
OUTCOMES
$36M pipeline accelerated
earlier translational feasibility confirmation
3 delivery vectors validated
disease-relevant cellular targeting pathways
4 indications advanced
toward translational therapeutic readiness milestones
Challenges
Targeting
- •Mutation identification complexity
- •Off-target editing risks
Delivery
- •Cell-specific delivery barriers
- •Translational validation gaps
Solutions
01
Mutation Identification
Identification of disease-causing genetic mutations.
- Mapped pathogenic mutation loci
- Structured diagnostic validation pipelines
02
Precision Correction Design
Design of precise CRISPR-based correction mechanisms.
- Engineered targeted correction constructs
- Minimized unintended genomic edits
- Optimized editing specificity workflows
03
Delivery Strategy Development
Development of delivery strategies for affected cell types.
- Evaluated vector delivery approaches
- Targeted disease-relevant tissues
- Improved cellular uptake efficiency
04
Preclinical Validation Pipelines
Preclinical validation pipelines for safety and efficacy.
- Established safety screening workflows
- Validated therapeutic response signals
- Structured translational readiness checkpoints